- Threats to Construct Validity: These occur when the operationalization fails to reflect the construct. For example, mono-operation bias happens when a researcher relies on only one single way to measure a variable. Hypothesis guessing occurs when participants figure out the study's purpose and change their behavior accordingly.
- Threats to External Validity: These are factors that prevent a researcher from generalizing their findings to other people, places, or times.
Exam Tip: If a question asks about the "truth of cause-effect inferences," think Internal Validity. If it asks about the "legitimacy of the measurement of an abstract idea," think Construct Validity.
The Evolution of Research Ethics
The history of research is marked by both great progress and profound tragedy. Ethical guidelines were not created in a vacuum; they were often written in response to human rights violations.
Historical Milestones
Following the atrocities committed by Nazi doctors during WWII, the Nuremberg Code was established, providing ten essential principles for human research. Later, the Declaration of Helsinki provided a set of principles specifically to guide medical research practice.
In the United States, two major events shaped the landscape:
- The Thalidomide Tragedy: This tragedy, involving severe birth defects in children whose mothers took the sedative thalidomide, led to the Kefauver-Harris Amendments. These amendments required drug manufacturers to prove both the effectiveness and the safety of their products.
- The Tuskegee Syphilis Study: This was a 40-year observational study involving low-income African American men who were misled into believing they were receiving treatment for syphilis when they were actually being left untreated.
In response to these ethical failures, the U.S. Congress passed the National Research Act (1974), which led to the creation of the Belmont Report.
The Three Pillars of the Belmont Report
The Belmont Report established three foundational ethical principles that govern all modern research involving human participants:
- Respect for Persons: Individuals must be treated as autonomous agents. This requires informed consent—the process of informing participants about all procedures and risks. For vulnerable populations (such as children or prisoners) who may not have full decision-making capacity, extra protections are required. For children, researchers must seek assent (an affirmative agreement to participate) in addition to parental consent.
- Beneficence: Researchers have an obligation to maximize potential benefits while minimizing any expected harm to the participant's well-being.
- Justice: The burdens and benefits of research should be distributed fairly. Researchers should not exploit specific populations based on their status or easy accessibility.
Protecting the Participant
Beyond the core principles, researchers must implement specific procedural safeguards to protect participants.
Participation and Rights
Participants must engage in voluntary participation, meaning they can choose to join or leave a study at any time without facing negative consequences. They also possess the right to service, ensuring they receive the most appropriate care relevant to the condition being studied.
Privacy and Data Management
Protecting personal information is a requirement. Researchers use several methods to manage privacy:
- Anonymity: The highest level of protection, where even the researchers cannot link the data back to a specific individual.
- Confidentiality: An assurance that identifying information will not be released to anyone outside the research team.
- De-identification: The technical process of removing identifying information from data sets.
Sometimes, researchers use deception (intentionally using false or misleading information) to prevent participants from changing their behavior. However, this must be justified, and the researcher must perform a debriefing—providing the participant with the full truth once the study is complete.
Oversight and Clinical Phases
Before any research begins, a protocol (a detailed document summarizing the study's purpose and procedures) must be reviewed and approved by an Institutional Review Board (IRB). The IRB acts as an independent panel to ensure the safety and rights of participants are protected.
In clinical settings, particularly when testing new medications, research progresses through distinct stages:
- Phase I Study: Testing a new drug in a small group of people for the first time to evaluate its safety.
- Phase II Study: Testing the drug in a larger group to see if it is effective.
- Phase III Study: Testing the drug in large groups using highly controlled designs to confirm effectiveness and monitor side effects.
Summary Table: Clinical Trial Progression
| Phase | Primary Goal | Participant Size |
|---|
| Phase I | Safety | Small |
| Phase II | Effectiveness | Larger |
| Phase III | Confirmation/Large-scale testing | Large |